{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:49:09Z","timestamp":1762955349840},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T00:00:00Z","timestamp":1407974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00296-014-3102-3","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T22:42:09Z","timestamp":1407969729000},"page":"479-484","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The CC chemokine ligand 2 (CCL2) polymorphism \u22122518A\/G is associated with gout in the Chinese Han male population"],"prefix":"10.1007","volume":"35","author":[{"given":"Ruixia","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingsheng","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,14]]},"reference":[{"key":"3102_CR1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","volume":"143","author":"HK Choi","year":"2005","unstructured":"Choi HK, Mount DB, Reginato AM (2005) Pathogenesis of gout. Ann Intern Med 143:499\u2013516","journal-title":"Ann Intern Med"},{"key":"3102_CR2","first-page":"973","volume":"78","author":"A Matsukawa","year":"1998","unstructured":"Matsukawa A, Miyazaki S, Maeda T, Tanase S, Feng L et al (1998) Production and regulation of monocyte chemoattractant protein-1 in lipopolysaccharide-or monosodium urate crystal-induced arthritis in rabbits: roles of tumor necrosis factor alpha, interleukin-1, and interleukin-8. Lab Invest 78:973\u2013985","journal-title":"Lab Invest"},{"key":"3102_CR3","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/art.24625","volume":"60","author":"W Zheng","year":"2009","unstructured":"Zheng W, Li R, Pan H, He D, Xu R et al (2009) Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1\u03b2 through the NF-\u03baB and MAPK pathways in rheumatoid arthritis. Arthritis Rheum 60:1957\u20131965","journal-title":"Arthritis Rheum"},{"key":"3102_CR4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/clin.1993.1153","volume":"69","author":"M Harigai","year":"1993","unstructured":"Harigai M, Hara M, Yoshimura T, Leonard EJ, Inoue K et al (1993) Monocyte chemoattractant protein-1 (CCL2) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol 69:83\u201391","journal-title":"Clin Immunol Immunopathol"},{"key":"3102_CR5","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/rheumatology\/kes326","volume":"52","author":"R Grainger","year":"2013","unstructured":"Grainger R, McLaughlin RJ, Harrison AA, Harper JL (2013) Hyperuricaemia elevates circulating CCL2 levels and primes monocyte trafficking in subjects with inter-critical gout. Rheumatology 52:1018\u20131021","journal-title":"Rheumatology"},{"key":"3102_CR6","doi-asserted-by":"crossref","unstructured":"Fenoglio et al. (2004) CCL2 in Alzheimer\u2019s disease patients: a \u22122518G polymorphism and serum levels by neurobiol aging 25(9):1169\u20131173","DOI":"10.1016\/j.neurobiolaging.2003.11.008"},{"key":"3102_CR7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.0022-202X.2004.23512.x","volume":"124","author":"S Karrer","year":"2005","unstructured":"Karrer S, Bosserhoff AK, Weiderer P, Distler O, Landthaler M et al (2005) The \u22122518 promotor polymorphism in the CCL2 gene is associated with systemic sclerosis. J Invest Dermatol 124:92\u201398","journal-title":"J Invest Dermatol"},{"key":"3102_CR8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.arcmed.2013.12.007","volume":"45","author":"Q Gao","year":"2014","unstructured":"Gao Q, Du Q, Zhang H, Guo C, Lu S et al (2014) Monocyte chemotactic protein-1 \u22122518 gene polymorphism and susceptibility to spinal tuberculosis. Arch Med Res 45:183\u2013187","journal-title":"Arch Med Res"},{"key":"3102_CR9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3109\/08820139.2013.789910","volume":"42","author":"GG Song","year":"2013","unstructured":"Song GG, Lee YH (2013) The CTLA-4 and CCL2 polymorphisms and susceptibility to systemic sclerosis: a meta-analysis. Immunol Invest 42:481\u2013492","journal-title":"Immunol Invest"},{"key":"3102_CR10","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1007\/s11033-012-1773-y","volume":"39","author":"HL Lin","year":"2012","unstructured":"Lin HL, Ueng KC, Hsieh YS, Chiang WL, Yang SF et al (2012) Impact of CCL2 and CCR-2 gene polymorphisms on coronary artery disease susceptibility. Mol Biol Rep 39:9023\u20139030","journal-title":"Mol Biol Rep"},{"key":"3102_CR11","first-page":"740","volume":"34","author":"KS Brown","year":"2007","unstructured":"Brown KS, Nackos E, Morthala S, Jensen LE, Whitehead AS et al (2007) Monocyte chemoattractant protein-1: plasma concentrations and A (\u22122518) G promoter polymorphism of its gene in systemic lupus erythematosus. J Rheumatol 34:740\u2013746","journal-title":"J Rheumatol"},{"key":"3102_CR12","first-page":"1859","volume":"35","author":"Z Miao","year":"2008","unstructured":"Miao Z, Li C, Chen Y, Zhao S, Wang Y et al (2008) Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35:1859\u20131864","journal-title":"J Rheumatol"},{"key":"3102_CR13","first-page":"S435","volume":"11","author":"AJ Luk","year":"2005","unstructured":"Luk AJ, Simkin PA (2005) Epidemiology of hyperuricemia and gout. Am J Manag Care 11:S435\u2013S442","journal-title":"Am J Manag Care"},{"key":"3102_CR14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s11926-007-0041-y","volume":"9","author":"JS Sundy","year":"2007","unstructured":"Sundy JS, Hershfield MS (2007) Uricase and other novel agents for the management of patients with treatment-failure gout. Curr Rheumatol Rep 9:258\u2013264","journal-title":"Curr Rheumatol Rep"},{"key":"3102_CR15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ et al (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895\u2013900","journal-title":"Arthritis Rheum"},{"key":"3102_CR16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","volume":"64","author":"TR Mikuls","year":"2005","unstructured":"Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr et al (2005) Gout epidemiology: results from the UK general practice research database, 1990\u20131999. Ann Rheum Dis 64:267\u2013272","journal-title":"Ann Rheum Dis"},{"key":"3102_CR17","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4049\/jimmunol.172.2.1256","volume":"172","author":"M Pierer","year":"2004","unstructured":"Pierer M, Rethage J, Seibl R, Lauener R, Brentano F et al (2004) Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol 172:1256\u20131265","journal-title":"J Immunol"},{"key":"3102_CR18","first-page":"258","volume":"54","author":"TC Yao","year":"2006","unstructured":"Yao TC, Kuo ML, See LC, Ou LS, Lee WI et al (2006) RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile rheumatoid arthritis: a six-year longitudinal study. Arthritis Rheum 54:258\u20132593","journal-title":"Arthritis Rheum"},{"key":"3102_CR19","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1177\/0022034510376041","volume":"89","author":"N Ogura","year":"2010","unstructured":"Ogura N, Satoh K, Akutsu M, Tobe M, Kuyama K et al (2010) CCL2 production in temporomandibular joint inflammation. J Dent Res 89:1117\u20131122","journal-title":"J Dent Res"},{"key":"3102_CR20","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/art.22023","volume":"54","author":"S Ahmed","year":"2006","unstructured":"Ahmed S, Pakozdi A, Koch AE (2006) Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 54:2393\u20132401","journal-title":"Arthritis Rheum"},{"key":"3102_CR21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/03009742.2012.726372","volume":"42","author":"S Liu","year":"2013","unstructured":"Liu S, Yin C, Chu N, Han L, Li C (2013) IL-8-251T\/A and IL-12B 1188A\/C polymorphisms are associated with gout in a Chinese male population. Scand J Rheumatol 42:150\u2013158","journal-title":"Scand J Rheumatol"},{"key":"3102_CR22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.5114\/ceji.2013.39760","volume":"38","author":"S Liu","year":"2013","unstructured":"Liu S, Wang H, Li C (2013) Relationship between -238A\/G and -308A\/G polymorphisms in the promoter region of TNF-\u03b1 and susceptibility to gout in the Chinese Han male population. Cent Eur J Immunol 38:449\u2013453","journal-title":"Cent Eur J Immunol"},{"key":"3102_CR23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/rheumatology\/ken054","volume":"47","author":"SJ Chang","year":"2008","unstructured":"Chang SJ, Chen CJ, Tsai FC, Lai HM, Tsai PC et al (2008) Associations between gout tophus and polymorphisms 869T\/C and -509C\/T in transforming growth factor beta1 gene. Rheumatology 47:617\u2013621","journal-title":"Rheumatology"},{"key":"3102_CR24","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/rheumatology\/kem235","volume":"46","author":"SJ Chang","year":"2007","unstructured":"Chang SJ, Tsai PC, Chen CJ, Lai HM, Ko YC (2007) The polymorphism \u2212863C\/A in tumour necrosis factor-alpha gene contributes an independent association to gout. Rheumatology 46:1662\u20131666","journal-title":"Rheumatology"},{"key":"3102_CR25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/bbrc.1999.0796","volume":"259","author":"BH Rovin","year":"1999","unstructured":"Rovin BH, Lu L, Saxena R (1999) A novel polymorphism in the CCL2 gene regulatory region that influences CCL2 expression. Biochem Biophys Res Commun 259:344\u2013348","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"3102_CR26","doi-asserted-by":"crossref","first-page":"e49498","DOI":"10.1371\/journal.pone.0049498","volume":"7","author":"MH Pham","year":"2012","unstructured":"Pham MH, Bonello GB, Castiblanco J et al (2012) The rs1024611 regulatory region polymorphism is associated with CCL2 allelic expression imbalance. PLoS ONE 7(11):e49498","journal-title":"PLoS ONE"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3102-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-014-3102-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3102-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T22:08:37Z","timestamp":1565734117000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-014-3102-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,14]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["3102"],"URL":"https:\/\/doi.org\/10.1007\/s00296-014-3102-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,14]]}}}